Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 18, 2020
Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort StudyRosie K Singleton, Alicia K Heath, Joanna L Clasen, et al.
Antioxidants (Basel, Switzerland)|August 27, 2021
Polyphenol Intake and Epithelial Ovarian Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) StudyCatalina Londoño, Valerie Cayssials, Izar de Villasante, et al.
European Journal of Epidemiology|June 20, 2021
Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) studyCarlota Castro-Espin, Antonio Agudo, Catalina Bonet, et al.
BMC Medicine|April 18, 2022
Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohortManon Cairat, Sabina Rinaldi, Anne-Sophie Navionis, et al.
British Journal of Cancer|January 15, 2022
Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancerTrasias Mukama, Renée Turzanski Fortner, Verena Katzke, et al.
International Journal of Cancer|July 26, 2024
Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patientsJinze Li, Jacqueline Roshelli Baker, Elom K Aglago, et al.
European Journal of Epidemiology|May 14, 2015
An epidemiological model for prediction of endometrial cancer risk in EuropeAnika Hüsing, Laure Dossus, Pietro Ferrari, et al.
International Journal of Cancer|June 17, 2011
Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort studyInger T Gram, Annekatrin Lukanova, Ilene Brill, et al.
International Journal of Cancer|April 4, 2020
Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohortAnnika Idahl, Charlotte Le Cornet, Sandra González Maldonado, et al.
Pageof 13